HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of 24-Nor-Ursodeoxycholic Acid on Hepatic Disposition of [(18)F]Ciprofloxacin, a Positron Emission Tomography Study in Mice.

Abstract
24-nor-ursodeoxycholic acid (norUDCA) is a novel therapeutic approach to cholestatic liver diseases. In mouse models of cholestasis, norUDCA induces basolateral multidrug resistance-associated proteins 4 (Mrp4) and 3 in hepatocytes, which provide alternative escape routes for bile acids accumulating during cholestasis but could also result in altered hepatic disposition of concomitantly administered substrate drugs. We used positron emission tomography imaging to study the influence of norUDCA on hepatic disposition of the model Mrp4 substrate [(18)F]ciprofloxacin in wild-type and Mdr2((-/-)) mice, a model of cholestasis. Animals underwent [(18)F]ciprofloxacin positron emission tomography at baseline and after norUDCA treatment. After norUDCA treatment, liver-to-blood area under the curve ratio of [(18)F]ciprofloxacin was significantly decreased compared to baseline, both in wild-type (-34.0 ± 2.1%) and Mdr2((-/-)) mice (-20.5 ± 6.0%). [(18)F]Ciprofloxacin uptake clearance from blood into liver was reduced by -17.1 ± 9.0% in wild-type and by -20.1 ± 7.3% in Mdr2((-/-)) mice. Real-time PCR analysis showed significant increases in hepatic Mrp4 and multidrug resistance-associated protein 3 mRNA after norUDCA. Transport experiments in organic anion transporting polypeptide (OATP)1B1-, OATP1B3-, and OATP2B1-transfected cells revealed weak transport of [(14)C]ciprofloxacin by OATP1B3 and OATP2B1 and no inhibition by norUDCA. In conclusion, our data suggest that changes in hepatic [(18)F]ciprofloxacin disposition in mice after norUDCA treatment were caused by induction of basolateral Mrp4 in hepatocytes.
AuthorsThomas Wanek, Emina Halilbasic, Michele Visentin, Severin Mairinger, Kerstin Römermann, Bruno Stieger, Claudia Kuntner, Markus Müller, Oliver Langer, Michael Trauner
JournalJournal of pharmaceutical sciences (J Pharm Sci) Vol. 105 Issue 1 Pg. 106-12 (Jan 2016) ISSN: 1520-6017 [Electronic] United States
PMID26852845 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B
  • Abcc4 protein, mouse
  • Fluorine Radioisotopes
  • Multidrug Resistance-Associated Proteins
  • Ciprofloxacin
  • Ursodeoxycholic Acid
  • 24-norursodeoxycholic acid
Topics
  • ATP Binding Cassette Transporter, Subfamily B (genetics, metabolism)
  • Animals
  • Biological Transport
  • CHO Cells
  • Cholestasis (drug therapy, metabolism)
  • Ciprofloxacin (blood, pharmacokinetics)
  • Cricetulus
  • Disease Models, Animal
  • Female
  • Fluorine Radioisotopes
  • Liver (diagnostic imaging, metabolism)
  • Mice, Knockout
  • Multidrug Resistance-Associated Proteins (metabolism)
  • Organ Specificity
  • Positron-Emission Tomography
  • Substrate Specificity
  • Tissue Distribution
  • Ursodeoxycholic Acid (analogs & derivatives, pharmacokinetics, therapeutic use)
  • ATP-Binding Cassette Sub-Family B Member 4

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: